<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00667134</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00009559</org_study_id>
    <nct_id>NCT00667134</nct_id>
  </id_info>
  <brief_title>Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis</brief_title>
  <official_title>Stimulatory Autoantibodies to the PDGFR and Phosphorylation of the PDGFR in Patients With Systemic Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to determine if subjects with .systemic sclerosis have stimulatory
      autoantibodies to the PDGF receptor and to confirm activation (phosphorylation) of the PDGF
      receptor in skin sites with varying degrees of skin thickening
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pilot study to assess whether patients with systemic sclerosis have stimulatory
      autoantibodies to the PDGF receptor and to confirm activation (phosphorylation) of the PDGF
      receptor in skin sites with varying degrees of skin thickening
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stimulatory autoantibodies to the PDGF receptor</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phosphorylation of the PDGF receptor in patients with systemic sclerosis</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">26</enrollment>
  <condition>Systemic Sclerosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Subjects with diffuse scleroderma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Subjects with limited scleroderma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Subjects without a fibrosing or autoimmune disease.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      skin serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects from a tertiary care clinic specializing in scleroderma. Controls recruited by
        subjects being biopsied.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Fulfill the American College of Rheumatology criteria for systemic sclerosis or:

          2. Have no diseases that result in primary fibrosis of an organ system, including the
             skin and do not have an autoimmune disease

        Exclusion Criteria:

          1. If the subject has systemic sclerosis resulting from an environmental exposure

          2. If the subject has an autoimmune disease excluding scleroderma

          3. If the subject has an active infection (including, but not limited to hepatitis B,
             hepatitis C and HIV)

          4. If the subject has been treated with cyclophosphamide in the past 8 weeks.

          5. If the subject is prone to bleeding because they are on medications that thin the
             blood or have a low platelet count.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristine Phillips, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie A Konkle, BSN</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Medical School</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2008</study_first_submitted>
  <study_first_submitted_qc>April 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2008</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Kristine Phillips</investigator_full_name>
    <investigator_title>clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>systemic sclerosis autoantibodies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autoantibodies</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

